# K102742: Nasal Cease

- Pathway: 510(k) (Traditional)
- Applicant: Catalina, Inc.
- Decided: Feb 2, 2011 after 133 days
- Product code: QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K821150 (1982). 24 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 26 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K070211: Traumarrest and Bleedarrest Hemostatic Particles and Foam, Hemostasis, LLC (2007) Summary page 5.
- K041446: Nasalcease, Les Laboratorires Brothier, S.A. (2004) Summary page 5.

## Most influential descendants
- K183622: NasalCEASE and BleedCEASE (2019), 0 descendants of its own

## Indications for use
This device has the following intended use. NasalCEASE is intended to be used as a topical dressing for the local management of bleeding such as minor cuts, lacerations, and abrasions. NasalCEASE is already approved for treatment of minor nosebleeds. It is intended to be marketed and sold as an Over-The-Counter device. The device is not intended to be used for medium or severe wounds or bleeding.

Source page: https://510kreport.com/device/K102742
Methodology: https://510kreport.com/methodology